NASDAQ:ACRX - AcelRx Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$2.90 -0.10 (-3.33 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$3.00
Today's Range$2.85 - $3.05
52-Week Range$1.55 - $5.75
Volume1.06 million shs
Average Volume572,717 shs
Market Capitalization$159.09 million
P/E Ratio-2.64
Dividend YieldN/A
Beta2.4

Analyst Ratings

AcelRx Pharmaceuticals (NASDAQ:ACRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for AcelRx Pharmaceuticals in the last 12 months. Their average twelve-month price target is $5.20, suggesting that the stock has a possible upside of 79.31%. The high price target for ACRX is $8.00 and the low price target for ACRX is $2.00. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.562.632.572.57
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.20$5.50$5.40$6.8333
Price Target Upside: 79.31% upside34.15% upside200.00% upside279.63% upside

AcelRx Pharmaceuticals (NASDAQ:ACRX) Consensus Price Target History

Price Target History for AcelRx Pharmaceuticals (NASDAQ:ACRX)

AcelRx Pharmaceuticals (NASDAQ:ACRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/12/2018OppenheimerInitiated CoverageHoldHighView Rating Details
6/14/2018Cantor FitzgeraldReiterated RatingOverweightMediumView Rating Details
10/27/2017HC WainwrightReiterated RatingBuy$5.00N/AView Rating Details
10/13/2017Piper Jaffray CompaniesReiterated RatingHold$2.00N/AView Rating Details
10/13/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$6.00 ➝ $5.00N/AView Rating Details
10/13/2017Jefferies Financial GroupDowngradeBuy ➝ HoldN/AView Rating Details
10/12/2017Roth CapitalSet Price TargetBuy$8.00N/AView Rating Details
8/9/2017Stifel NicolausUpgradeHold ➝ BuyHighView Rating Details
8/1/2017CowenReiterated RatingHoldHighView Rating Details
(Data available from 7/18/2016 forward)
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.